Argus Research Maintains Buy on CVS Health, Raises Price Target to $114
Argus Research analyst Steve Silver maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $104 to $114.
Benzinga16 gün önceCVS
Viking Global Bets Big On SpaceX While Ditching CoreWeave, Alphabet in Q2
Viking Global Investors' second-quarter 13F shows new stakes in SPCX, MS, QCOM, CVS and exits in CRWV and GOOGL.
Benzinga18 gün önceCVS
Viking Global Investors Reports Share Stake Of 3.7 Mln Shares In CVS Health Corp
- Sec Filing
Benzinga21 gün önceCVS
CVS Health (CVS) Rolls Out New PBM Tools As Employer Trust Grows
CVS Health (NYSE:CVS) reports that employers show higher trust in pharmacy benefit managers to manage drug costs and access to complex treatments, according to a new CVS Caremark survey. The company is rolling out new digital tools for its PBM clients to manage pharmacy benefits and monitor prescription spending. CVS is expanding coverage for biosimilars and GLP-1 therapies across its pharmacy network with a focus on affordability. Affordability driven changes across the CVS pharmacy network...
Yahoo21 gün önceCVS
The Top 5 Analyst Questions From CVS Health’s Q2 Earnings Call
CVS Health’s second quarter was marked by better-than-expected revenue and profit, but investor sentiment was dampened by rising concerns over sustainability of these results. Management cited strong performance across all business segments, particularly from specialty pharmacy and Medicare Advantage, as key drivers. CEO David Joyner acknowledged, “the cumulative impact of these actions [in Aetna and Caremark] is starting to come through clearly in our results.” However, management also highligh
Yahoo21 gün önceCVS
CVS Health Enhances Its Direct-to-Consumer Weight Management Offerings To Improve Access, Affordability, Care and Support for GLP-1 Medications
WOONSOCKET, RI / ACCESS Newswire / August 13, 2026 /Originally published on CVS Health Company Newsroom CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options. New collaboration with Eli Lilly and Company will provide ...
Yahoo22 gün önceCVS